POSIFIT S.A.S is the industrial development operator of NANCYCLOTEP.
POSIFIT S.A.S. is a partner of Curium International for the production and quality control of the following two specialties, under AMM Curium International and manufactured within the pharmaceutical establishment of Curium International:
DOPACIS ([18F]-fluorolévodopa): a specialty used in PET imaging for neurological (Parkinson’s disease) or oncology (glioma, neuroendocrine tumors) indications.
The manufacturing of DOPACIS began in July 2013.
CISCHOLINE / FLUOROCHOLINE Curium INTERNATIONAL ([18F]-fluorométhylcholine): a specialty used in PET imaging for oncological indications (prostate cancer).
The production of CISCHOLINE / FLUOROCHOLINE CIS BIO INTERNATIONAL began in March 2016.
In the first quarter of 2020, POSIFIT S.A.S. will be a pharmaceutical establishment with access to a cyclotron for the production of Fluor 18, Carbon 11, Zirconium 89 and Copper 64 as well as a GMP production laboratory with the capacity to manufacture radiopharmaceuticals under contract for industrial companies.